Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black spots on the tablet surface due to microbial contamination. The observance of black spots was reported in a product quality complaint
Similar Posts
The Future of Registries in Oncology – 08/27/2025
The public meeting will be held on Wednesday August 27, 2025 and Thursday August 28, 2025, from 10 a.m. to 1 p.m. The meeting agenda, biographies, additional materials, and any other updates will also be posted to this website as they become available.Accelerated Approval Program
To allow for earlier approval of drugs that treat serious conditions and fill an unmet medical need based on a surrogate endpointFDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain
FDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. The agency advises wholesalers, retail pharmacies, health care practitioners and patients to check the proMHRA CEO Lawrence Tallon welcomes Life Sciences Sector Plan
The Life Sciences Sector plan was released today (16 July 2025)
MHRA Safety Roundup: August 2025
Summary of the latest safety advice for medicines and medical device users
Applicator Recall: Integra LifeSciences Removes MicroMyst Applicators Due to Potential Sterility Concerns
MicroMyst Applicators are being recalled due to potential non-sterile product., but these devices may not have been properly sterilized.